MAG
VYNT

Millrace Asset Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Millrace Asset Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,188
Closed -$588K – 58
2015
Q4 		$588K Sell
1,188
-137
-10% -$99K 0.62% 49
2015
Q3 		$1.55M Buy
1,325
+184
+16% +$282K 1.67% 34
2015
Q2 		$2.01M Buy
1,141
+34
+3% +$52.9K 2.1% 17
2015
Q1 		$1.3M Sell
1,107
-141
-11% -$167K 1.43% 35
2014
Q4 		$1.25M Buy
+1,248
New +$1.25M 1.3% 43

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Eagle Global Advisors
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
Tocqueville Asset Management
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Millrace Asset Group's VYNT Position: Q1 2016 in Review

Millrace Asset Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2016, closing a stake of 1,188 shares — an estimated $588K sold.

Millrace Asset Group first reported a position in VYNT in Q4 2014 and held it in 5 quarters. The position peaked at $2.01M in Q2 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2016.

  • Millrace Asset Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Millrace Asset Group sold 1,188 Vyant Bio, Inc. Common Stock shares in Q1 2016, an estimated $588K.
  • Millrace Asset Group first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and held it in 5 quarters.
  • Millrace Asset Group's Vyant Bio, Inc. Common Stock position peaked at $2.01M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2016.

Based on Millrace Asset Group's 13F filing for Q1 2016, filed 13 May 2016.